Get the Stockscreener App
14.87
1.98%
-0.30
Pulse Biosciences Inc stock is traded at $14.87, with a volume of 95,488.
It is down -1.98% in the last 24 hours and down -3.44% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
See More
Previous Close:
$15.17
Open:
$15.07
24h Volume:
95,488
Relative Volume:
0.56
Market Cap:
$1.00B
Revenue:
-
Net Income/Loss:
$-46.13M
P/E Ratio:
-18.31
EPS:
-0.8123
Net Cash Flow:
$-34.10M
1W Performance:
-4.98%
1M Performance:
-3.44%
6M Performance:
-17.94%
1Y Performance:
-18.92%
1-Day Range:
$14.77
$15.28
1-Week Range:
$14.77
$15.84
52-Week Range:
$13.50
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
14.87 | 1.02B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
488.61 | 179.91B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
183.63 | 52.33B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.90 | 45.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.50 | 40.08B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
279.10 | 16.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | Oppenheimer | Outperform |
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Pulse Biosciences Inc. Stock Analysis and ForecastTremendous gains - PrintWeekIndia
Is Pulse Biosciences Inc. a good long term investmentPhenomenal capital appreciation - Autocar Professional
What analysts say about Pulse Biosciences Inc. stockUnmatched profit growth - jammulinksnews.com
What drives Pulse Biosciences Inc. stock priceDynamic portfolio growth - Autocar Professional
Should I buy Pulse Biosciences Inc. stock before earningsFree Deep Market Trend Analysis - Newser
How Pulse Biosciences Inc. stock performs during market volatilityDaily Top Gainers - beatles.ru
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 - BioSpace
Pulse Biosciences Appoints New VP of Accounting - The Globe and Mail
What makes Pulse Biosciences Inc. stock price move sharplyBreakout Momentum Alerts - Newser
Why Pulse Biosciences Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Pulse Biosciences appoints Steven T. Weber as principal accounting officer - Investing.com
Don't Ignore The Insider Selling In Pulse Biosciences - 富途牛牛
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential - Investing.com Canada
Oppenheimer initiates coverage on Pulse Biosciences with an Outperform rating, $22 PT. - AInvest
Oppenheimer & Co. Inc. Sells 5,000 Shares of Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
(PLSE) Long Term Investment Analysis - news.stocktradersdaily.com
GAMMA Investing LLC Boosts Stock Position in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Farther Finance Advisors LLC Has $143,000 Stock Holdings in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Insider Sell: Darrin Uecker Sells 30,000 Shares of Pulse Bioscie - GuruFocus
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Nuveen Asset Management LLC Has $990,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
BNP Paribas Financial Markets Has $35,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):